MarketPulse

acquisition targets

2 articles
Investing.comInvesting.com··Chris Markoch

Gene-Editing Pioneers Emerge as M&A Targets Amid $300B Biotech Patent Cliff

Biotech M&A surges as $300B patent cliff looms by 2030. Three gene-editing firms positioned as acquisition targets offer varying risk profiles.
BMYCELGrMRKBEAMCRSP+1patent cliffCRISPR
The Motley FoolThe Motley Fool··Anders Bylund

Nvidia's Optical Tech Deals Ignite Broader Optoelectronics Rally

Nvidia's partnerships with Coherent and Lumentum boosted those stocks 14-15%, while smaller optics firms nLIGHT and Applied Optoelectronics surged 20-21% on acquisition speculation.
NVDAAAOILITECOHRLASRsemiconductorAI data centers